Business UpdateJul 15, 2026, 08:11 AM
POMDOCTOR Advances Healthcare Data Strategy for AI-Powered Chronic Disease Management
AI Summary
POMDOCTOR Limited announced its ongoing efforts to strengthen its healthcare data ecosystem to enhance AI-powered chronic disease management. The company is leveraging real-world data (RWD), artificial intelligence (AI), wearable technologies, and remote patient monitoring (RPM) to enable personalized and predictive healthcare. Market projections indicate significant growth for the global RWD market, with estimates ranging from $2.15 billion in 2026 to $7.11 billion by 2035, driven by increased adoption in clinical research and personalized healthcare solutions.
Key Highlights
- POMDOCTOR advances healthcare data asset strategy to strengthen AI-powered chronic disease management.
- Leveraging real-world data (RWD), AI, wearable tech, and remote patient monitoring (RPM).
- Global RWD market projected to grow from $2.15 billion (2026) to $7.11 billion (2035).
- This represents a compound annual growth rate (CAGR) of 14.23% (Precedence Research).
- Another estimate projects RWD market to grow from $2.73 billion (2026) to $7.08 billion (2033).
- This represents a CAGR of 14.6% during the forecast period (Coherent Market Insights).
- Company aims to build a closed-loop ecosystem to continuously strengthen AI capabilities.
Price Impact
More from POM